Similar Items: FREM1 promotes anlotinib resistance in non-small cell lung cancer through regulation of extracellular matrix organization
- Fascin-1 expression in non-small cell lung cancer and its diagnostic implications
- An overview of circular RNAs in the regulation of autophagy in lung cancer
- miR-34a-5p-mediated inhibition on the KRT5/DSP axis blunts cancer stem cell properties and cisplatin resistance in non-small cell lung cancer
- Synergistic efficacy of radiotherapy and immunotherapy enhances clinical outcomes in patients with advanced non-small cell lung cancer
- Clinical outcomes of immune checkpoint inhibitor based therapy in NRG1 fusion positive non small cell lung cancer a retrospective study
- Clinical outcomes of concomitant anti-PD-1 therapy and denosumab treatment in non-small cell lung cancer patients with bone metastasis: a single-center retrospective study